The global genomic data set for real world evidence (RWE) applications market is poised for substantial growth, underpinned by the rising adoption of precision medicine, increasing integration of genomics with real-world data, and technological advancements in bioinformatics. Valued at USD 477.20 million in 2023, the market is expected to reach USD 526.10 million in...